rs12474969

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000607241.2(ENSG00000271855):​n.1065G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.229 in 150,764 control chromosomes in the GnomAD database, including 4,646 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4646 hom., cov: 33)

Consequence

ENSG00000271855
ENST00000607241.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.508

Publications

5 publications found
Variant links:
Genes affected
ADAM17 (HGNC:195): (ADAM metallopeptidase domain 17) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The encoded preproprotein is proteolytically processed to generate the mature protease. The encoded protease functions in the ectodomain shedding of tumor necrosis factor-alpha, in which soluble tumor necrosis factor-alpha is released from the membrane-bound precursor. This protease also functions in the processing of numerous other substrates, including cell adhesion proteins, cytokine and growth factor receptors and epidermal growth factor (EGF) receptor ligands, and plays a prominent role in the activation of the Notch signaling pathway. Elevated expression of this gene has been observed in specific cell types derived from psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn's disease patients, suggesting that the encoded protein may play a role in autoimmune disease. Additionally, this protease may play a role in viral infection through its cleavage of ACE2, the cellular receptor for SARS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2020]
ADAM17 Gene-Disease associations (from GenCC):
  • inflammatory skin and bowel disease, neonatal, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • neonatal inflammatory skin and bowel disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.304 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000271855ENST00000607241.2 linkn.1065G>A non_coding_transcript_exon_variant Exon 1 of 1 6
ENSG00000271855ENST00000716659.1 linkn.307+346G>A intron_variant Intron 1 of 2
ENSG00000271855ENST00000716660.1 linkn.278+346G>A intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.229
AC:
34503
AN:
150652
Hom.:
4650
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.109
Gnomad AMI
AF:
0.288
Gnomad AMR
AF:
0.199
Gnomad ASJ
AF:
0.310
Gnomad EAS
AF:
0.00520
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.298
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.308
Gnomad OTH
AF:
0.266
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.229
AC:
34501
AN:
150764
Hom.:
4646
Cov.:
33
AF XY:
0.226
AC XY:
16606
AN XY:
73616
show subpopulations
African (AFR)
AF:
0.109
AC:
4532
AN:
41428
American (AMR)
AF:
0.198
AC:
2974
AN:
14984
Ashkenazi Jewish (ASJ)
AF:
0.310
AC:
1075
AN:
3470
East Asian (EAS)
AF:
0.00521
AC:
27
AN:
5180
South Asian (SAS)
AF:
0.249
AC:
1195
AN:
4800
European-Finnish (FIN)
AF:
0.298
AC:
3041
AN:
10208
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.308
AC:
20743
AN:
67394
Other (OTH)
AF:
0.266
AC:
557
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1308
2616
3923
5231
6539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.271
Hom.:
1163
Bravo
AF:
0.210

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.6
DANN
Benign
0.84
PhyloP100
0.51

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12474969; hg19: chr2-9697067; API